Martek Supplying lifesDHA to Mission Pharmacal

COLUMBIA, Md.—Martek Biosciences Corp. (www.martek.com) entered into a five-year license and supply agreement with San Antonio-based Mission Pharmacal to supply Martek’s life’sDHA™ for Mission Pharamcal’s prescription pregnancy and nursing products in the United States and other designated territories. Mission Pharmacal will display the life’sDHA logo on product packaging and related promotional materials. Mission Pharmacal introduced its first product with the Martek docosahexaenoic acid (DHA) ingredient in early 2006, with Citracal® Prenatal + DHA with life’sDHA added to its prescription prenatal vitamin line.